Sol-Gel Technologies Ltd. Ordinary Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for SLGL, updated each market day.
SLGL AI Sentiment
AI sees no strong directional signal for Sol-Gel Technologies Ltd. Ordinary Shares stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Sol-Gel Technologies Ltd. Ordinary Shares
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
Exchange
Market Cap
$233,724,345
Cap Tier
Employees
28
Listed Since
Feb. 1, 2018
Website
SLGL Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
SLGL Volatility
Sol-Gel Technologies Ltd. Ordinary Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
